P.L.E.A.S.E., a novel transdermal delivery method for high molecular weight drugs, creates controlled aqueous micropores through the stratum corneum into the epidermis.
Oclaro worked with Pantec to deliver a customized quasi continuous wave (QCW) sub-assembly laser diode solution that delivers the performance and reliability needed, at a price point that enables wide-spread adoption in the consumer space.
Oclaro’s QCW operation enabled Pantec to develop a compact laser device P.L.E.A.S.E. Professional that will be used for both transdermal delivery and tissue ablation, mainly for the dermatologic and aesthetic markets.
The device will initially be sold in Europe with plans to bring the product into selected markets worldwide, starting in 2011.
Oclaro Industrial and Consumer Lasers sales director Gunnar Stolze said the combination of Pantec’s P.L.E.A.S.E. platform technology with Oclaro’s manufacturing capabilities delivers innovation to the consumer that revolutionizes modern day medical and cosmetic procedures such as drug delivery and tissue ablation.
